Cancer

 

U-M Health Cancer is a nationally ranked specialty area by US News & World Report 2022-23.

If you or a loved one are facing cancer, come to the University of Michigan Rogel Cancer Center for care.  Our center has earned the National Cancer Institute’s “Comprehensive” designation by meeting strict guidelines for clinical and laboratory research, testing of new therapies, and cancer prevention and control research. We are the only place in Michigan – and one of only a handful of cancer centers in the country – to provide true multidisciplinary cancer clinics in most cancer types. Each of these team of specialists offer one-stop access to comprehensive, cutting-edge treatment tailored for each type of cancer (learn more by clicking one of the links):

Adrenal

Brain and Spine

Colon

Eye

Kidney

Lung

Merkel Cell

Ovarian

Rectal

Skin

Thyroid
Bladder

Breast

Endocrine

Gastrointestinal

Leukemia

Lymphoma

Multiple Myeloma

Pancreatic

Sarcoma

Testicular

Uterine
Bone

Cervical

Esophageal

Head and neck

Liver

Melanoma

Oral

Prostate

Sinus

Throat

 

Caring for the whole person — not just the cancer patient

At the Rogel Cancer Center we offer support patients -- and their families -- during treatment. A patient's cancer care team includes not only the subspecialty doctors and nurses, but cancer specialists in psychology, social work, art therapy, nutrition, finance, and countless other areas through our patient and family support services. This support is fully integrated into the patient's treatment plan because we know that cancer affects not only the organs of the body, but the whole person and the whole family.

Our renowned Rogel Cancer Center is also a founding member of the National Comprehensive Cancer Network, a consortium of premiere cancer centers formed to develop national guidelines to ensure consistent, high-quality, and cost-effective cancer care.

For more information on the services, treatment options and care offered go to the Rogel Cancer Center website or call one of our nurses at the Cancer AnswerLine at 800-865-1125.